Why Is Urine Drug Testing Not Used More Often in Practice?

Pain Practice

Volumn 10, Issue 6, 2010, Pages 493-496

  Bair, Matthew J ^a   Krebs, Erin E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; INSULIN; MORPHINE; OPIATE AGONIST; OXYCODONE; WARFARIN;

ANTICOAGULANT THERAPY; CHRONIC PAIN; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG FATALITY; DRUG MISUSE; DRUG MONITORING; DRUG SCREENING; DRUG USE; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HUMAN; INSULIN TREATMENT; MEDICAID; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; SELF REPORT; URINALYSIS;

EID: 78049474749     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2010.00425.x     Document Type: Editorial

References (21)

1. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710-1714.
2. Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44:1005-1010.
3. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-179.
4. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176-188.
5. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31:506-511.
6. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009;22:1-8.
7. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573-582.
8. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15:184-191.
9. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-130.
10. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:131-146.
11. VA/DoD. Clinical guideline for management of opioid therapy for chronic pain. Department of Veteran Affairs and Department of Defense, Prepared by The Management of Opioid Therapy for Chronic Pain Working Group. Version 2.0 2010. Available at
12. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta. 2002;315:125-135.
13. Webster LR, Dove B. Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners. North Branch, MN: Sunrise River Press; 2007.
14. Pergolizzi J, Pappagallo M, Stauffer JW, et al. The role of urine drug testing for patients on opioid therapy. Pain Pract. 2010;10:497-507.
15. Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791-796.
16. Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22:1859-1865.
17. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GL. Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Res Manag. 2007;12:39-47.
18. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147-159.
19. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712-720.
20. Matthias MS, Nyland KA, Huffman MA, et al. Urine drug testing and opioids contracts (agreements) to monitor patients treated with opioids for chronic pain. J Gen Intern Med. 2009;24(suppl 1):399.
21. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8:573-584.